Pasithea Therapeutics Corp
KTTA
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.32M
Close$
$13.25
2037% upside
Current Fair Value
2037% upsideUndervalued by 2037% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.32 Million |
|---|---|
| Enterprise Value | $-50,395,053,628.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.91 |
| Beta | 0.22 |
| Outstanding Shares | 24,338,000 |
Return
| Return on Equity | -48.03% |
|---|---|
| Return on Assets | -46.72% |
| Return on Invested Capital | -14.64% |
Valuation & Multiples
| P/E Ratio | -0.88 |
|---|---|
| PEG | 4.53 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 6.27 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 3, 2026
EPS Estimate
$-3.40
Average shareholder expectationRevenue Estimate
$300,000
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-0.16
Average shareholder expectationRevenue Estimate
$300,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 182.32%▲ 8.68% |
|---|---|
| Total Invested | $9.52M▼ 42.97% |
| Investors Holding | 21▼ 4.00% |
ESG Score
No data
About Pasithea Therapeutics Corp
2 employees